StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Oculis Holding AG
NasdaqGM:OCS
Sector
Location
Market Cap
USD 977.55 M
Share Price
USD 19.16
Avg Daily Volume
36,771
Change (1 day)
1.03%
Change (1 year)
63.72%
Change (YTD)
12.68%
Oculis Holding AG Total Assets for the year ending December 31, 2024: USD 132.52 M
Oculis Holding AG Total Assets is USD 132.52 M for the year ending December 31, 2024, a -2.43% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Oculis Holding AG Total Assets for the year ending December 31, 2023 was USD 135.82 M, a 238.90% change year over year.
-
Oculis Holding AG Total Assets for the year ending December 31, 2022 was USD 40.08 M, a -37.01% change year over year.
-
Oculis Holding AG Total Assets for the year ending December 31, 2021 was USD 63.62 M, a 243.78% change year over year.
-
Oculis Holding AG Total Assets for the year ending December 31, 2020 was USD 18.51 M.
Competitors
Glaukos Corporation
USD 103.63
GKOS
+1.11
1.08%
Santen Pharmaceutical Co., Ltd.
USD 11.49
4536.T
-0.02
-0.15%
PharmaResearch Co., Ltd.
USD 368.22
214450.KQ
+24.18
7.03%
Bausch Health Companies Inc.
USD 7.10
BHC.TO
+0.43
6.51%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.22
300573.SZ
-0.10
-1.36%
Tarsus Pharmaceuticals, Inc.
USD 40.45
TARS
+0.46
1.15%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Glaukos Corporation
USD 103.63
GKOS
+1.11
1.08%
Santen Pharmaceutical Co., Ltd.
USD 11.49
4536.T
-0.02
-0.15%
PharmaResearch Co., Ltd.
USD 368.22
214450.KQ
+24.18
7.03%
Bausch Health Companies Inc.
USD 7.10
BHC.TO
+0.43
6.51%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.22
300573.SZ
-0.10
-1.36%
Tarsus Pharmaceuticals, Inc.
USD 40.45
TARS
+0.46
1.15%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%